Hytrin and Pregabalin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Hytrin (terazosin hydrochloride) and Pregabalin (pregabalin). Common drug interactions include chest pain among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Hytrin and Pregabalin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Hytrin?
Hytrin has active ingredients of terazosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 7,501 Hytrin users. Check the latest studies of Hytrin.
What is Pregabalin?
Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.
13 people who take Hytrin and Pregabalin together, and have interactions are studied.

What are the common drug interactions of Hytrin and Pregabalin, by gender? *:
female:
- Chest pain
- Dehydration (dryness resulting from the removal of water)
- Blood creatinine increased
- Blood urea increased
- Pneumonia
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Drug hypersensitivity
- Pneumonia haemophilus (haemophilus influenzae type b (hib) bacteria include pneumonia)
- Renal failure (kidney dysfunction)
- Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
male:
- Chronic kidney disease
- Abdominal pain upper
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Hypersomnia (excessive daytime sleepiness (eds))
- Nephrogenic anaemia (anaemia due to kidney disease)
- Pallor
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Renal failure (kidney dysfunction)
- Asthenia (weakness)
- Chest pain
What are the common drug interactions of Hytrin and Pregabalin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Abdominal pain upper
- Chronic kidney disease
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
60+:
- Chest pain
- Dehydration (dryness resulting from the removal of water)
- Dizziness postural
- Drug hypersensitivity
- Dyspnoea exertional (breathlessness or shortness of breath)
- Faeces discoloured
- Hyperhidrosis (abnormally increased sweating)
- Hypersomnia (excessive daytime sleepiness (eds))
- Pallor
- Palpitations (feelings or sensations that your heart is pounding or racing)
What are the existing conditions these people have? *
- Pain: 10 people, 76.92%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 76.92%
- Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 9 people, 69.23%
- High Blood Pressure: 9 people, 69.23%
- Neuralgia (pain in one or more nerves): 5 people, 38.46%
- Diarrhea: 4 people, 30.77%
- Lactose Intolerance (inability to digest lactose): 3 people, 23.08%
- Cardiac Disorder: 2 people, 15.38%
- Type 2 Diabetes: 1 person, 7.69%
- Prostate Cancer: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Hytrin and Pregabalin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Hytrin (7,501 reports)
- Pregabalin (74,069 reports)
Browse all drug interactions of Hytrin and Pregabalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Hytrin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pregabalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Hytrin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pregabalin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
How the study uses the data?
The study uses data from the FDA. It is based on terazosin hydrochloride and pregabalin (the active ingredients of Hytrin and Pregabalin, respectively), and Hytrin and Pregabalin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Aspirin and Carmustine - now
- Drug interactions of Lidocaine Hydrochloride and Omeprazole Magnesium - 28 seconds ago
- Drug interactions of Elmiron and Skelaxin - 31 seconds ago
- Could Tramadol Hydrochloride cause Cellulitis Aggravated? - 41 seconds ago
- Could Plaquenil cause Tooth Disorder? - 46 seconds ago
- Could Ibu cause Pulmonary Mass? - 47 seconds ago
- Wound and Tremor - a minute ago
- Could Hydrocortisone Acetate cause Neoplasm Progression? - a minute ago
- Chromium Picolinate vs. Mounjaro, side effect and effectiveness comparison - a minute ago
- Drug interactions of Multivitamin and Metronidazole - a minute ago